PR
PreveCeutical Medical Inc.
PRVCF · OTC
$0.02 -3.37% (-$0.00)
1M +37.98%
Market Cap $14.7M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A PEG N/A
P/E N/A
P/FFO N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
57 /100
Average Asset turnover 0.00x
ROIC 339.03%
ROA 109.38%
Debt
0 /100
High Int. coverage -10.44x
Current ratio 0.15x
Debt/Assets N/A
Stability
39 /100
Moderate Profitable years 0
Beta 0.07x
EPS volatility 19.88%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PRVCF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stephen Van Deventer
Employees
7
Headquarters
Vancouver